Results 111 to 120 of about 3,741,440 (311)

Mode of delivery is not associated with celiac disease

, 2018
Stine Dydensborg Sander,1,2 Anne Vinkel Hansen,3,4 Ketil Størdal,5,6 Anne-Marie Nybo Andersen,3 Joseph A Murray,7 Steffen Husby1,2 1Hans Christian Andersen Children’s Hospital, Odense University Hospital, Odense, Denmark; 2Institute of ...
Hansen AV, Størdal K, Nybo Andersen AM, Husby S, Murray JA, Dydensborg Sander S   +5 more
core  

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

Molecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur, Joel Rodrigues Vitória, Manuel Saiselet, Ligia Craciun, Denis Larsimont, Anne Lefort, Frédérick Libert, Carine Maenhaut, Sabine Costagliola, Maxime Tarabichi, Mirian Romitti, Vincent Detours   +11 more
wiley   +1 more source

Mode of delivery according to severity of CHD.

, 2016
Mode of delivery according to severity of CHD.
Moritz Hamann (3600281), Bettina Kuschel (3600275), Joris Hrycyk (3600272), Harald Kaemmerer (3600284), KTM Schneider (3600278), Nicole Nagdyman (3600287)   +5 more
core   +1 more source

Cancer‐associated mutations in endometriosis reframe a benign disease through molecular oncology

Molecular Oncology, EarlyView.
This review aims to comprehensively analyse cancer‐associated somatic mutations (CAMs) present in endometriotic lesions, emphasizing their biological roles, spatial distribution and implications for translational applications in medicine. By contextualizing a benign state within a genomic framework, this analysis seeks to establish its value as a ...
Clarissa Mujacic, Maria Concetta Vitale, Rita Siino, Emilia Di Giovanni, Carla Ferrante Bannera, Enrico Di Marco, Andrea Gottardo, Tancredi Didier Bazan Russo, Nadia Barraco, Alessandro Perez, Valerio Gristina, Antonio Galvano, Giuseppe Badalamenti, Antonio Russo, Viviana Bazan, Lorena Incorvaia   +15 more
wiley   +1 more source

Influence of mode of delivery on infant gut microbiota composition: a pilot study

Journal of Obstetrics and Gynaecology
Background Microbial colonisation in infants is initially dependent on the mother and is affected by the mode of delivery. Understanding these impacts is crucial as the early-life gut microbiota plays a vital role in immune development, metabolism, and ...
Li Yu, Yong Guo, Jie-Ling Wu
doaj   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

Associations between mode of delivery and maternal outcomes.

, 2017
Associations between mode of delivery and maternal outcomes.
Lei Hou (274359), Liying Zou (579194), Susan Hellerstein (3737746), Allison Vitonis (1348806), Xin Wang (91924), Yan Ruan (579193), Weiyuan Zhang (180941)   +6 more
core   +1 more source

Castration‐resistant prostate cancer cells are addicted to the high activity of cyclin‐dependent kinase 2

Molecular Oncology, EarlyView.
We show that emergence of castration‐resistant prostate (CRPC) is associated with significant upregulation of cyclins that positively regulate cyclin‐dependent kinase 2 (CDK2) and concomitant downregulation of CDK4 cyclins. This renders CRPC cells dependent on the high activity of CDK2, and CDK2 inhibitors synergistically sensitize CRPC cells to both ...
Joyeeta Chatterjee, Alessia Marin, Shivani Yalala, Harri M. Itkonen   +3 more
wiley   +1 more source

Mode of delivery, gestational age at birth and outcomes.

, 2017
Mode of delivery, gestational age at birth and outcomes.
A. Metin Gülmezoglu (142912), Hany Abdel Aleem (3694948), Anke Diemert (3690634), Lisa Neerup Jensen (3694930), Pisake Lumbiganon (118480), Sameera A. Talegawkar (3694933), Alexandra Benachi (78557), Ann Tabor (384342), Antoinette Tshefu Kitoto (3694951), Lawrence D. Platt (3694939), Alka Kriplani (3694942), Rogelio Gonzalez Perez (3694945), Mariana Widmer (232499), Daniel Giordano (3531389), Torvid Kiserud (141246), Jadsada Thinkhamrop (3694927), José Guilherme Cecatti (3694924), Kurt Hecher (3690646), Guillermo Carroli (3265008), José Carvalho (3694936), Mark A. Hanson (114427), Gilda Piaggio (3573137)   +21 more
core   +1 more source